PT97082A - Processo para a preparacao de uma composicao farmaceutica contendo il-4,util para aumentar a resposta imunitaria a agressoes de antigenios infecciosos - Google Patents

Processo para a preparacao de uma composicao farmaceutica contendo il-4,util para aumentar a resposta imunitaria a agressoes de antigenios infecciosos

Info

Publication number
PT97082A
PT97082A PT97082A PT9708291A PT97082A PT 97082 A PT97082 A PT 97082A PT 97082 A PT97082 A PT 97082A PT 9708291 A PT9708291 A PT 9708291A PT 97082 A PT97082 A PT 97082A
Authority
PT
Portugal
Prior art keywords
pharmaceutical composition
agents
agressoes
useful
preparation
Prior art date
Application number
PT97082A
Other languages
English (en)
Other versions
PT97082B (pt
Inventor
Jerome Schwartz
Claude H Nash
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PT97082A publication Critical patent/PT97082A/pt
Publication of PT97082B publication Critical patent/PT97082B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT97082A 1990-03-21 1991-03-20 Processo para a preparacao de uma composicao farmaceutica contendo il-4,util para aumentar a resposta imunitaria a agressoes de antigenios infecciosos PT97082B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49683290A 1990-03-21 1990-03-21

Publications (2)

Publication Number Publication Date
PT97082A true PT97082A (pt) 1991-11-29
PT97082B PT97082B (pt) 1998-07-31

Family

ID=23974340

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97082A PT97082B (pt) 1990-03-21 1991-03-20 Processo para a preparacao de uma composicao farmaceutica contendo il-4,util para aumentar a resposta imunitaria a agressoes de antigenios infecciosos

Country Status (19)

Country Link
EP (1) EP0521916B1 (pt)
JP (1) JPH05505799A (pt)
CN (1) CN1055116A (pt)
AT (1) ATE133074T1 (pt)
AU (1) AU656889B2 (pt)
CA (1) CA2078676A1 (pt)
DE (1) DE69116552T2 (pt)
DK (1) DK0521916T3 (pt)
ES (1) ES2082201T3 (pt)
FI (1) FI924215A0 (pt)
GR (1) GR3019018T3 (pt)
HU (1) HUT63062A (pt)
IE (1) IE72204B1 (pt)
IL (1) IL97600A0 (pt)
MY (1) MY108672A (pt)
OA (1) OA09672A (pt)
PT (1) PT97082B (pt)
WO (1) WO1991014450A1 (pt)
ZA (1) ZA912037B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100191223B1 (ko) * 1989-07-28 1999-06-15 둘락 노먼 씨. 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물
US5827670A (en) * 1990-08-02 1998-10-27 Fred Hutchinson Cancer Research Center Methods of isolating and detecting bone marrow stromal cells with VCAM-1-specific antibodies
US7449186B1 (en) * 1990-08-02 2008-11-11 Fred Hutchinson Cancer Research Center Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies
CZ119993A3 (en) * 1990-12-19 1994-02-16 Schering Corp The use of il-4 for increasing immune response to immunogens in vaccines
JPH0747545B2 (ja) * 1991-01-10 1995-05-24 シェリング・コーポレーション 創傷治癒及び修復の修復段階を促進し、かつ感染した創傷及び糖尿病哺乳類の創傷の治癒を促進するためのｉｌ−４の用途
GB9124347D0 (en) * 1991-11-15 1992-01-08 Isis Innovation Treatment of macrophages
CA2142862C (en) * 1992-08-19 2000-05-30 Jerome Schwartz Method for inhibiting hiv replication using il-4

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
EP0302429B1 (en) * 1987-08-03 1993-07-28 Tasuku Honjo Novel human interleukin 4, expression vectors for human interleukin 4 and transformants containing the same
JPH0236129A (ja) * 1988-07-22 1990-02-06 Ajinomoto Co Inc ワクチン効果増強剤
JPH0611706B2 (ja) * 1989-01-20 1994-02-16 ザ ユニバーシティ オブ メルボルン フィブリン溶解

Also Published As

Publication number Publication date
EP0521916A1 (en) 1993-01-13
IE72204B1 (en) 1997-04-09
DE69116552T2 (de) 1996-05-30
FI924215A (fi) 1992-09-21
AU656889B2 (en) 1995-02-23
MY108672A (en) 1996-10-31
JPH05505799A (ja) 1993-08-26
ES2082201T3 (es) 1996-03-16
ATE133074T1 (de) 1996-02-15
WO1991014450A1 (en) 1991-10-03
EP0521916B1 (en) 1996-01-17
DK0521916T3 (da) 1996-03-04
OA09672A (en) 1993-05-15
IE910921A1 (en) 1991-09-25
AU7469091A (en) 1991-10-21
CA2078676A1 (en) 1991-09-22
DE69116552D1 (de) 1996-02-29
PT97082B (pt) 1998-07-31
ZA912037B (en) 1992-03-25
IL97600A0 (en) 1992-06-21
GR3019018T3 (en) 1996-05-31
FI924215A0 (fi) 1992-09-21
CN1055116A (zh) 1991-10-09
HUT63062A (en) 1993-07-28

Similar Documents

Publication Publication Date Title
MX9304089A (es) Uso de gm-csf como una vacuna adyuvante.
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
BR9909915A (pt) Composições adjuvantes
BR9907995A (pt) Métodos imunológicos para modular miostatina em sujeitos vertebrados
DE69729887D1 (de) Purin-l-nukleoside, deren analoga und verwendungen
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
ES2057191T5 (es) Metodo de produccion para una composicion que contiene proteinas.
ES2149776T3 (es) Modulacion, inducida por un morfogeno, de la respuesta inflamatoria.
ATE50499T1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
PT97082A (pt) Processo para a preparacao de uma composicao farmaceutica contendo il-4,util para aumentar a resposta imunitaria a agressoes de antigenios infecciosos
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
DK0563254T3 (da) Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner
ATE93388T1 (de) Paracetamol enthaltende arzneizubereitung.
ATE229981T1 (de) Glykolisierte cytokine
EP0351876A3 (en) Composition for potentiating vaccination effect
FI981624A (fi) Koostumukset ja menetelmät Borrelia burgdorferi antigeenien annostelemiseksi
DE3879837D1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
RU93043610A (ru) Фармацевтическая композиция для усиления первичной иммуно-реакции у млекопитающих, способ усиления первичной иммуно-реакции и применение интерлейкина-4 для усиления первичной иммуно-реакции у млекопитающих, набор лекарственных средств
ITRM910038A1 (it) Composizioni farmaceutiche aventi come principio attivo calcitonina da somministrarsi per via intranasale.
IT1228135B (it) Composizione farmaceutica sterile per la somministrazione per via iniettabile della citidindifosfocolina veicolata tramite i liposomi

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910724

FG3A Patent granted, date of granting

Effective date: 19980417

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20011031